Cell-based assays for drug discovery

Cancer immunotherapy strategies can be divided in three main categories including cytokines and immunomodulatory agents, antibody-based, and cell-based therapies. Explicyte’s expertise and advanced technologies have been harnessed so as to develop and build a cell-based service portfolio for immuno-oncology drug discovery. Our in vitro models & assays are sensitive, quantitative, and high throughput-compatible, thereby allowing to characterize and understand test compound’s effects, and identify single immunotherapeutic candidates or combination strategies that elicit immune cell functions and/or tumor cell sensitivity.

Alongside this, bespoke cell-based assays can be set up and used to address specific questions and meet our Sponsors’ expectations.